224 related articles for article (PubMed ID: 29176494)
1. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.
Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D;
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
3. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
Boon M; Calvo-Lerma J; Claes I; Havermans T; Asseiceira I; Bulfamante A; Garriga M; Masip E; van Schijndel BAM; Fornes V; Barreto C; Colombo C; Crespo P; Vicente S; Janssens H; Hulst J; Witters P; Nobili R; Pereira L; Ruperto M; Van der Wiel E; Mainz JG; De Boeck K; Ribes-Koninckx C
J Cyst Fibros; 2020 Jul; 19(4):562-568. PubMed ID: 32335023
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Woestenenk JW; van der Ent CK; Houwen RH
J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyrotropinemia in newly diagnosed cystic fibrosis patients with pancreatic insufficiency reversed by enzyme therapy.
Giannakopoulos A; Katelaris A; Noni M; Karakonstantakis T; Kanaka-Gantenbein C; Doudounakis S
Eur J Pediatr; 2018 May; 177(5):775-779. PubMed ID: 29487998
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
7. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life.
Leung DH; Heltshe SL; Borowitz D; Gelfond D; Kloster M; Heubi JE; Stalvey M; Ramsey BW;
JAMA Pediatr; 2017 Jun; 171(6):546-554. PubMed ID: 28437538
[TBL] [Abstract][Full Text] [Related]
8. Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis.
Schall JI; Bentley T; Stallings VA
J Pediatr Gastroenterol Nutr; 2006 Nov; 43(5):651-9. PubMed ID: 17130744
[TBL] [Abstract][Full Text] [Related]
9. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
10. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
11. Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Olsen MF; Kjøller-Svarre MS; Møller G; Katzenstein TL; Nielsen BU; Pressler T; Lewis JI; Mathiesen IH; Mølgaard C; Faurholt-Jepsen D
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405943
[TBL] [Abstract][Full Text] [Related]
12. Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening.
Munck A; Boulkedid R; Weiss L; Foucaud P; Wizla-Derambure N; Reix P; Bremont F; Derelle J; Schroedt J; Alberti C;
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):123-130. PubMed ID: 29543697
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis.
Schechter MS; Michel S; Liu S; Seo BW; Kapoor M; Khurmi R; Haupt M
J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):520-526. PubMed ID: 30052568
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
15. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
Borowitz D; Stevens C; Brettman LR; Campion M; Wilschanski M; Thompson H;
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):248-57. PubMed ID: 22266487
[TBL] [Abstract][Full Text] [Related]
16. Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration.
Borowitz D; Gelfond D; Maguiness K; Heubi JE; Ramsey B
J Cyst Fibros; 2013 Dec; 12(6):784-5. PubMed ID: 23809508
[TBL] [Abstract][Full Text] [Related]
17. Impact of timing of PERT on gastrointestinal symptoms in Danish children and adolescents with CF.
Raun AMT; Brekke G; Mølgaard C; Jaudszus A; Mainz JG; Pressler T; Skov M
Acta Paediatr; 2022 Feb; 111(2):432-439. PubMed ID: 34626004
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
Bartels RH; Bourdon C; Potani I; Mhango B; van den Brink DA; Mponda JS; Muller Kobold AC; Bandsma RH; Boele van Hensbroek M; Voskuijl WP
J Pediatr; 2017 Nov; 190():85-92.e2. PubMed ID: 28912050
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review).
Somaraju UR; Solis-Moya A
Paediatr Respir Rev; 2015 Mar; 16(2):108-9. PubMed ID: 25497671
[No Abstract] [Full Text] [Related]
20. Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results From the Baby Observational and Nutrition Study.
Sathe M; Huang R; Heltshe S; Eng A; Borenstein E; Miller SI; Hoffman L; Gelfond D; Leung DH; Borowitz D; Ramsey B; Freeman AJ
J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):395-402. PubMed ID: 34016873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
